Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
DATE PUBLISHED: 2020 08
JOURNAL:J Invest Dermatol
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/32004568?dopt=Abstract
Volume:140
ISSUE:8
To evaluate the safety and efficacy of bermekimab, an interleukin-1⍺ inhibitor, in the treatment of hidradenitis suppurativa (HS).
